probing the synergistic effect of pre-biotics & iron fortificants in anemic subjects

Conditions: Iron-deficiency

Summary: hypothesis: synergistic effect of pre-biotics and iron fortificants will enhance the bioavailability of iron; thereby improving the body iron reserves. a double blind, randomized controlled trail will be conducted on iron deficient female adults (age 18-25 years) in order to determine the synergistic effect of pre-biotics and iron fortificants in anemic human subjects. 75 iron deficient females will be randomly divided into 5 groups (d0, d1, d2, d3 and d4), each having 15 study subjects and will be given varying doses of feso4 and nafeedta and inulin and gos. blood samples will be collected from overnight fasted women from each group on monthly basis up to three months. various biomarkers for iron absorption, lfts, rfts, and immunoglobulins will be estimated.

study design a double blind, randomized controlled trial will be used for the purpose of this study. study site the study will be conducted in islamabad and/or lahore, depending on the availability of the required sample size with the desired profiles. study duration the trial will last for 12 weeks. study population the study population will consist of university going iron deficient female adults (age 18-25 years). inclusion and exclusion criteria inclusion criteria all willing anemic female adults without any chronic diseases such as diabetes or hypertension will be included in the study. exclusion criteria married females or those with chronic diseases or those already taking iron and/or prebiotic supplements will be excluded from the study. sampling sampling technique the technique of convenience sampling will be used for the current study. sample size each group will consist of 15 study subjects for the purpose of convenience and the total sample size will be 75. treatment plan for this phase of the study, 4 best treatment combinations of pre-biotics (inulin \& galactooligosaccharides) and iron fortificants (feso4 and nafeedta) will be chosen. study participants will be randomly chosen to receive either the best treatment combination 1, 2, 3, 4 or the placebo for 12 weeks on daily basis. efficacy trials blood samples will be collected from overnight fasted women from each group on monthly basis up to three months. hematological analysis the collected blood from respective groups will be assessed for hematological analysis. iron biomarkers obtained sera will also be analyzed for blood serum biomarkers like serum iron, folate, ferritin, transferrin saturation fraction \& tibc. liver function tests liver function tests including ast (aspartate aminotransferase), alt (alanine aminotransferase), alp (alkaline phosphatase) and total bilirubin will be conducted renal function tests blood urea (gldh-method) and creatinine (jaffe-method) levels will be determined using commercial kits. immunoglobulins immunoglobulins, including immunoglobulin a, immunoglobulin e, immunoglobulin g, and immunoglobulin m will be determined using the technique of elisa (enzyme linked immunosorbent assay).

Eligibility criteria:
inclusion criteria: * all willing anemic female adults without any chronic diseases such as diabetes or hypertension will be included in the study. exclusion criteria: * married females or those with chronic diseases or those already taking iron and/or prebiotic supplements will be excluded from the study.